ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 680,30
0,61%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Melinta Therapeutics Inc (MLNT)

  7. Melinta Therapeutics Inc (MLNT) Actualités

MLNT

Melinta Therapeutics (MLNT)

Melinta Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MLNT
DateHeureSourceTitreSymboleSociété
24/06/202022h02GlobeNewswire Inc.Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of TetraphaseNASDAQ:MLNTMelinta Therapeutics Inc
09/06/202022h02GlobeNewswire Inc.Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase PharmaceuticalsNASDAQ:MLNTMelinta Therapeutics Inc
04/03/202022h03GlobeNewswire Inc.Melinta Therapeutics Confirms Deerfield as Successful Bidder for CompanyNASDAQ:MLNTMelinta Therapeutics Inc
13/02/202022h02GlobeNewswire Inc.Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding ProceduresNASDAQ:MLNTMelinta Therapeutics Inc
05/02/202017h15Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:MLNTMelinta Therapeutics Inc
08/01/202022h39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
27/12/201915h02GlobeNewswire Inc.Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit FacilityNASDAQ:MLNTMelinta Therapeutics Inc
12/11/201923h07GlobeNewswire Inc.Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019NASDAQ:MLNTMelinta Therapeutics Inc
12/11/201923h00Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MLNTMelinta Therapeutics Inc
25/10/201918h54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNTMelinta Therapeutics Inc
24/10/201922h02GlobeNewswire Inc.Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Tr...NASDAQ:MLNTMelinta Therapeutics Inc
01/10/201916h07PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019NASDAQ:MLNTMelinta Therapeutics Inc
03/09/201922h05GlobeNewswire Inc.Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and DirectorNASDAQ:MLNTMelinta Therapeutics Inc
13/08/201912h02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MLNTMelinta Therapeutics Inc
09/08/201913h31GlobeNewswire Inc.Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession PlanNASDAQ:MLNTMelinta Therapeutics Inc
09/08/201913h30GlobeNewswire Inc.Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business UpdateNASDAQ:MLNTMelinta Therapeutics Inc
06/08/201923h04GlobeNewswire Inc.Melinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results ReportingNASDAQ:MLNTMelinta Therapeutics Inc
16/07/201913h30GlobeNewswire Inc.Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:MLNTMelinta Therapeutics Inc
10/07/201921h00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MLNTMelinta Therapeutics Inc
01/07/201915h13PR Newswire (US)X-Biotix Therapeutics Joins Antimicrobials Working GroupNASDAQ:MLNTMelinta Therapeutics Inc
26/06/201922h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNTMelinta Therapeutics Inc
20/06/201917h13PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2019NASDAQ:MLNTMelinta Therapeutics Inc
19/06/201913h30GlobeNewswire Inc.Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the ...NASDAQ:MLNTMelinta Therapeutics Inc
07/06/201915h27PR Newswire (US)Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Inno...NASDAQ:MLNTMelinta Therapeutics Inc
16/05/201923h31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MLNTMelinta Therapeutics Inc
09/05/201922h00GlobeNewswire Inc.Melinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:MLNTMelinta Therapeutics Inc
07/05/201913h30GlobeNewswire Inc.Melinta Therapeutics to Present at Making a Difference in Infectious Diseases (MAD-ID) 2019 Annual MeetingNASDAQ:MLNTMelinta Therapeutics Inc
02/05/201922h30GlobeNewswire Inc.Melinta Therapeutics to Report First Quarter 2019 Financial Results on May 9, 2019NASDAQ:MLNTMelinta Therapeutics Inc
30/04/201912h18Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MLNTMelinta Therapeutics Inc
12/04/201916h08PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology a...NASDAQ:MLNTMelinta Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MLNT

Dernières Valeurs Consultées

LSE
3LNG
Wt N.gas 3x Lev
TSX
QQC
Invesco Nasdaq 100 Index...
LSE
RI71
Citi Fun 28
BIT
P1VKW0
NLBNPIT1VKW0 20351221 4....
TG
A28VGX
HSBC
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés